Cargando…

1811. Minimizing Time to Optimal Therapy for Enterobacteriaceae Bloodstream Infections: Is Organism Identification Enough?

BACKGROUND: BSI due to ceftriaxone (CRO)-resistant ENT are increasing in frequency, and are associated with delays in time to appropriate therapy. However, treating all patients at risk for CRO-resistant organisms with empiric carbapenem (CARB) therapy risks over exposure. Strategies are needed to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cwengros, Laura N, Mynatt, Ryan P, Timbrook, Tristan T, Pogue, Jason M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253648/
http://dx.doi.org/10.1093/ofid/ofy210.1467